Natus medical inc (BABY)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Interest Paid, Excluding Capitalized Interest, Operating Activities

637

853

656

1,724

1,347

1,743

1,460

1,484

1,482

1,408

954

1,122

980

0

31

0

10

0

0

-2

2

70

55

123

186

227

138

333

613

274

194

9

12

20

25

21

48

Operating activities:
Net loss

-3,597

1,681

8,461

4,585

-30,398

-11,634

-5,574

-2,579

-3,148

-7,095

-8,512

-5,034

348

10,233

13,311

10,512

8,538

8,544

10,933

9,850

8,597

10,439

7,823

7,461

6,755

9,398

6,287

4,020

3,442

4,957

-1,747

324

289

-16,797

153

2,361

3,104

Adjustments to reconcile net loss to net cash provided by operating activities:
Excess tax benefit on the exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,800

933

3,317

1,054

3,679

1,100

552

2,194

2,472

234

322

81

-506

737

-505

-107

-

3

221

75

Provision for losses on accounts receivable

1,564

90

534

-837

1,797

1,038

1,782

3,171

918

1,313

1,632

5,353

1,719

183

180

408

352

551

362

307

276

430

463

-367

465

-169

214

-140

372

1,124

-151

92

254

-1,423

684

386

-5

Loss on commencement of sales-type leases

295

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

6,994

7,776

7,519

7,716

7,711

8,211

8,958

8,779

7,915

9,239

7,040

7,075

6,744

4,059

4,424

4,173

4,223

4,641

4,168

4,195

2,983

3,192

2,941

2,324

3,302

3,294

3,241

3,180

3,133

3,259

3,492

3,018

2,846

3,421

2,277

1,944

2,550

Loss on disposal of property and equipment

-42

33

0

-303

-179

-336

-250

-108

-52

35

-20

11

-5

8

-10

46

-15

5

0

0

0

-

-

-

-

141

-115

-20

-6

-334

-69

-9

-2

-80

-15

-167

-5

Warranty reserve

704

298

911

1,323

354

2,095

-902

2,100

-1,125

63

-401

2,902

2,806

-339

961

1,383

929

5,958

1,618

2,277

876

886

825

205

390

1,120

47

115

656

912

129

195

216

-2,693

107

549

569

Share-based compensation

2,291

1,975

1,915

1,908

2,554

1,605

9,814

3,270

2,362

2,222

2,248

2,219

2,756

2,051

1,954

2,102

2,901

1,571

1,891

1,760

1,731

1,358

1,527

1,568

1,609

1,470

1,429

1,819

1,360

1,413

2,471

1,379

1,157

1,440

1,911

1,593

1,524

Impairment charge for sale of entity

0

0

0

0

24,571

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

-14,570

7,473

1,880

-4,812

-14,358

8,154

-891

-4,306

2,242

16,813

4,762

6,532

2,366

-424

-11,705

2,672

-10,266

8,591

5,714

1,380

-413

3,681

2,630

-3,172

-708

-2,252

-2,531

-5,361

787

9,204

8,936

2,092

1,799

8,273

-7,394

1,941

-2,980

Inventories

3,443

-9,259

-401

-2,001

4,476

2,260

2,700

5,368

-2,885

-790

-699

-1,470

-4,622

1,315

6,705

-1,255

903

5,218

2,134

3,637

1,243

1,091

3,279

-1,427

-926

1,251

980

512

-64

-105

1,484

-2,685

-3,953

-4,613

-2,777

455

3,194

Prepaid expenses and other assets

1,060

-

-417

3,693

7,367

-

-743

9,751

5,390

-

-718

1,709

-2,386

-

11,468

1,778

15

-

3,332

-1,505

-778

-

-1,920

-1,792

1,936

-

169

846

-734

-

4,315

-417

321

-

-597

-1,601

1,166

Accounts payable

6,038

-2,974

5,124

-81

-3,436

7,904

-3,435

258

-622

8,145

-8,734

352

-1,148

1,097

-1,376

-896

-3,790

33

5,103

-2,945

1,079

-5,024

1,386

-1,300

-2,710

4,493

593

-3,171

-3,302

2,110

9,685

-166

-318

1,000

-3,301

-1,651

-3,110

Accrued liabilities

-9,329

-5,083

3,693

-1,301

-1,319

-3,495

-2,446

95

3,319

13,958

1,967

-2,245

-8,259

-479

-2,464

-336

-3,688

-2,581

3,406

-4,510

-2,492

12,446

-938

-2,152

-2,761

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

2,190

1,021

-368

757

1,982

331

58

373

1,314

658

998

441

-9,329

-11,115

24,871

-323

446

931

-830

-1,378

159

251

286

-598

-714

-

-

-

-

-

-

-

-

-

-

-

-

Deferred income tax

-103

2,547

2,861

-61

17

14,231

-191

-239

-87

12,738

-11,021

-4,757

-992

2,480

-106

171

-108

4,017

-867

-2,984

-1,709

1,741

-2,658

-479

-1,844

-2,679

192

680

304

8,203

-436

529

-86

2,656

-531

735

146

Accrued liabilities and deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,098

-3,235

-6,228

-

4,030

2,115

-342

-

-2,231

-82

386

Net cash provided by operating activities

17,362

12,147

23,866

17,554

6,493

14,064

7,630

5,001

6,325

5,478

3,934

9,038

1,276

4,185

35,509

13,611

19,382

1,924

15,405

5,711

13,812

8,958

14,042

13,459

5,684

16,082

16,041

5,609

-935

2,354

2,956

7,952

6,130

6,103

9,711

3,516

3,422

Investing activities:
Acquisition of businesses, net of cash acquired

-

-

-

-

-

-

-

-

-

48,296

-4,844

5,731

141,705

0

9,699

501

5,649

2,725

0

-519

12,078

0

0

0

4,925

0

0

0

18,600

-

-

-

-

-

-

-

-

Purchase of property and equipment

3,575

1,454

953

458

2,461

2,748

1,740

914

2,473

1,317

1,285

493

971

1,010

73

182

1,921

1,078

615

976

1,399

503

1,537

1,393

806

1,228

-917

827

687

-1,553

1,502

1,079

1,218

1,987

611

708

874

Acquisition of intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-32

268

890

0

517

388

541

35

60

1,047

99

669

-

-

-

-

-

-

-

-

Sale of intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Sales of short-term investments

-

-

-

-

-

-

-

-

-

0

0

9,084

24,935

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1,005

Net cash used in investing activities

-3,575

-1,454

-953

-471

-2,461

-2,776

-2,079

-1,061

-2,473

-49,613

3,559

2,860

-117,741

-9,600

-35,170

-926

-7,568

-3,771

-883

-1,347

-13,477

-1,020

-1,925

-1,934

-5,766

-1,288

-130

-926

-19,956

-1,032

-1,203

-59,010

-1,218

-3,089

-15,706

-708

131

Financing activities:
Proceeds from stock option exercises and Employee Stock Purchase Program purchases

0

1,442

519

1,406

268

933

5,423

4,515

577

1,219

174

1,825

248

1,080

343

1,584

623

4,172

371

4,396

1,319

5,695

1,061

3,154

6,300

3,884

1,250

1,732

2,115

887

200

640

130

451

470

1,072

326

Excess tax benefit on the exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,800

933

3,317

1,054

3,679

1,100

552

2,194

2,472

234

322

81

-506

737

-505

-107

-459

3

221

75

Repurchase of common stock

10,495

0

0

0

0

1

-1

894

4,736

0

0

960

1,308

1,032

1,503

7,691

9,063

2,173

3,837

4,203

1,312

1,226

2,199

1,208

0

-

-

-

-

-

-

-

-

-

-

-

-

Taxes paid related to net share settlement of equity awards

-1,883

-

-23

-6

-1,567

-

-4,847

-307

-19

-

-549

-539

-2,597

-

-1,362

-558

-2,017

-

-2,654

-1,189

-460

-

-1,960

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Principal payments of financing lease liability

133

74

139

100

165

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from borrowings

60,000

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of contingent consideration related to a business combination

-

-

-

-

-

-

0

0

147

-

446

500

2,000

-

0

0

1,284

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contingent consideration earn-out

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

664

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from short-term borrowings

-

-

-

-

-

-

-

-

-

-

50,000

0

10,000

0

0

10,000

6,000

0

0

0

0

-

-

-

-

-

-

-

22,000

-

-

-

-

0

569

810

1,174

Deferred debt issuance costs

-

-

-

-

-

-

-

-

-

0

316

0

38

0

533

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on borrowings

15,000

15,000

10,000

20,000

5,000

10,000

5,000

10,000

25,000

0

5,000

40,000

0

0

10,000

0

6,000

0

0

0

0

8,000

8,409

16,529

5,079

10,044

4,596

35,444

2,142

2,129

2,137

53

40

894

1,013

1,057

49

Net cash provided by (used in) financing activities

32,489

-13,725

-9,643

-18,700

-6,464

-9,078

-4,423

-6,686

-29,325

-2,168

43,863

-40,174

4,305

139,878

-13,055

3,335

-11,741

3,761

-5,187

1,657

601

109

-10,407

-14,031

3,415

-3,688

-1,029

-90

22,054

2,252

100

31,082

-17

-902

29

1,046

1,526

Exchange rate changes effect on cash and cash equivalents

-2,557

3,267

-2,217

203

-518

-277

-1,596

-6,817

994

2,848

746

4,801

2,387

-1,985

-2,495

-1,021

-1,257

-1,646

-372

218

-495

705

78

-1,065

150

808

400

-37

134

-17

690

-483

-295

-72

-1,004

-7

437

Net increase (decrease) in cash and cash equivalents

43,719

-

-

-

-2,950

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase (decrease) in cash and cash equivalents

-

-

-

-

-

1,933

-468

-9,563

-24,479

-43,455

52,102

-23,475

-109,773

132,478

-15,211

14,999

-1,184

268

8,963

6,239

441

8,752

1,788

-3,571

3,483

11,914

15,282

4,556

1,297

3,557

2,543

-20,459

4,600

2,040

-6,970

3,847

5,516

Supplemental disclosure of cash flow information:
Cash paid for income taxes

3,492

2,276

-1,159

4,104

1,224

1,301

712

5,577

1,657

1,428

1,256

2,770

286

8,320

269

3,805

3,950

4,816

2,857

2,342

149

935

782

3,381

574

3,047

2,334

3,313

4,214

1,935

2,142

1,433

1,432

-34

650

1,063

199

Non-cash investing activities:
Property and equipment included in accounts payable

131

54

-20

-106

141

85

-11

-256

349

91

-240

67

230

-25

95

-162

226

89

-9

37

172

-152

87

-78

265

1

-189

7

261

-

-

-

-

-

-

-

-

Inventory transferred to property and equipment

196

95

-384

446

143

457

461

132

161

71

162

528

245

63

878

153

209

259

204

216

377

596

244

112

398

-

-

-

-

-

-

-

-

-

-

-

-

Transfer of leased assets to sales-type leases

663

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-